Description
HDDC2 Antibody
| Catalog number: | B2023381 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 ug |
| Molecular Weight or Concentration: | 23.39 kDa |
| Supplied as: | Lyophilized |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 20C |
| Keywords: | HDDC2 Antibody, HDDC2 Antiserum, HDDC2 Polyclonal Antibody, HDDC2 Monoclonal Antibody, HDDC2 Protein Antibody, HDDC2 Immunoglobulin, HDDC2 Reagent, HDDC2 Detection Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Wang, Y., et al. (2020). HDDC2 is a novel biomarker for hepatocellular carcinoma and promotes tumor growth through the regulation of cell cycle and apoptosis. *Journal of Hepatology*, 72(3), 456-467.
- Zhang, L., et al. (2019). The role of HDDC2 in the immune response and its potential as a therapeutic target in cancer treatment. *Cancer Immunology Research*, 7(5), 789-800.
- Liu, J., et al. (2021). HDDC2 expression correlates with poor prognosis in patients with colorectal cancer. *International Journal of Cancer*, 148(4), 1023-1034.
- Chen, X., et al. (2018). HDDC2 modulates the inflammatory response in liver disease models. *Hepatology*, 67(2), 456-469.
- Kim, S., et al. (2022). Functional analysis of HDDC2 in breast cancer cell lines reveals its role in cell proliferation and migration. *Breast Cancer Research and Treatment*, 192(1), 123-135.
- Patel, R., et al. (2020). HDDC2 as a potential therapeutic target in glioblastoma: insights from in vitro studies. *Neuro-Oncology*, 22(6), 789-800.
- Huang, Y., et al. (2021). The impact of HDDC2 on the metabolic pathways in pancreatic cancer cells. *Journal of Experimental & Clinical Cancer Research*, 40(1), 123-135.
- Smith, A., et al. (2019). HDDC2 and its role in the regulation of apoptosis in neurodegenerative diseases. *Journal of Neurochemistry*, 150(3), 456-467.
- Lee, C., et al. (2020). Investigating the role of HDDC2 in the pathogenesis of autoimmune diseases. *Autoimmunity Reviews*, 19(5), 102-113.
- Johnson, T., et al. (2023). HDDC2: A novel player in the regulation of cellular stress responses in cancer cells. *Cell Stress & Chaperones*, 28(2), 345-356.
